Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-06-21 @ 3:09 PM
Study NCT ID:
NCT05764356
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-03-10
First Post:
2023-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
Sponsor:
Peking University First Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Novel Oral Anticoagulants | View |
| None | NOACs | View |
| None | Rivaroxaban | View |
| None | Apixaban | View |
| None | Edoxaban | View |
| None | Dabigatran | View |
| None | Ticagrelor | View |
| None | Pharmacodynamics | View |
| None | Pharmacogenomics | View |
| None | RNA Profile | View |
| None | Bleeding | View |
| None | Biomarker | View |
Keywords: